Guo X - Search Results

1

Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.

Li WZ, Lv X, Hu D, Lv SH, Liu GY, Liang H, Ye YF, Yang W, Zhang HX, Yuan TZ, Wang DS, Lu N, Ke LR, Tang WB, Tong LH, Chen ZJ, Liu T, Cao KJ, Mo HY, Guo L, Zhao C, Chen MY, Chen QY, Huang PY, Sun R, Qiu F, Luo DH, Wang L, Hua YJ, Tang LQ, Qian CN, Mai HQ, Guo X, Xiang YQ, Xia WX. Li WZ, et al. Among authors: guo x, guo l. JAMA Oncol. 2022 May 1;8(5):706-714. doi: 10.1001/jamaoncol.2022.0122. JAMA Oncol. 2022. PMID: 35323856 Free PMC article. Clinical Trial.

2

Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.

Qian CN, Guo X, Cao B, Kort EJ, Lee CC, Chen J, Wang LM, Mai WY, Min HQ, Hong MH, Vande Woude GF, Resau JH, Teh BT. Qian CN, et al. Among authors: guo x. Cancer Res. 2002 Jan 15;62(2):589-96. Cancer Res. 2002. PMID: 11809714

3

Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses.

Guo X, Lui WO, Qian CN, Chen JD, Gray SG, Rhodes D, Haab B, Stanbridge E, Wang H, Hong MH, Min HQ, Larsson C, Teh BT. Guo X, et al. Int J Oncol. 2002 Dec;21(6):1197-204. Int J Oncol. 2002. PMID: 12429968

4

[Expression of topoisomerase IIalpha in nasopharyngeal carcinoma and its clinical significance].

Xiang YQ, Min HQ, Hong MH, Cao SM, He JH, Hou JH, Guo X. Xiang YQ, et al. Among authors: guo x. Ai Zheng. 2004 Mar;23(3):322-5. Ai Zheng. 2004. PMID: 15025967 Chinese.

5

[Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma].

Guo L, Lin HX, Li FY, Li Q, Qiu F, Luo DH, Guo X, Hong MH. Guo L, et al. Among authors: guo x. Zhonghua Zhong Liu Za Zhi. 2004 Apr;26(4):250-3. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312392 Clinical Trial. Chinese.

6

[Clinical value of vascular endothelial growth factor detection in forecasting distant metastasis risk of nasopharyngeal carcinoma].

Guo X, Cao SM, Hong MH, Zhang CQ, Han AJ, Xiang YQ, Hou JH, Min HQ. Guo X, et al. Ai Zheng. 2004 Oct;23(10):1171-5. Ai Zheng. 2004. PMID: 15473929 Chinese.

7

High frequency of common deletion (4981 bp) in mitochondrial DNA in nasopharyngeal carcinoma and its correlation with patient age and clinical stages.

Shao JY, Li YH, Gao HY, Mai HQ, Zhang Y, Guo X, Zeng YX. Shao JY, et al. Among authors: guo x. Cancer Biol Ther. 2004 Dec;3(12):1270-4. doi: 10.4161/cbt.3.12.1243. Epub 2004 Dec 14. Cancer Biol Ther. 2004. PMID: 15477759

8

[Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma].

Mai HQ, Zeng ZY, Zhang HZ, Hou JH, Mo HY, Guo X, Min HQ, Hong MH. Mai HQ, et al. Among authors: guo x. Ai Zheng. 2005 May;24(5):611-5. Ai Zheng. 2005. PMID: 15890108 Chinese.

9

[Impact of pre-radiotherapy hemoglobin level on local control of nasopharyngeal carcinoma].

Mai HQ, Mo HY, Hong MH, Guo X, Deng MQ, Zhang F, Min HQ. Mai HQ, et al. Among authors: guo x. Ai Zheng. 2005 Jun;24(6):727-30. Ai Zheng. 2005. PMID: 15946489 Chinese.

10

Distinct serumal proteomic patterns between ascending and descending types of loco-regionally advanced nasopharyngeal carcinoma assessed by surface enhanced laser desorption ionization and artificial neural network analyses.

Guo X, Cao SM, Yu JK, Hong MH, Zhang CQ, Li NW, Xiang YQ, Qian CN, Hu X, Min HQ, Zeng YX. Guo X, et al. Chin Med J (Engl). 2005 Nov 20;118(22):1912-7. Chin Med J (Engl). 2005. PMID: 16313847 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29,767 results

Search Page